These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 34947888)

  • 1. Advanced CRISPR-Cas Effector Enzyme-Based Diagnostics for Infectious Diseases, Including COVID-19.
    Kwon S; Shin HY
    Life (Basel); 2021 Dec; 11(12):. PubMed ID: 34947888
    [TBL] [Abstract][Full Text] [Related]  

  • 2. iSCAN: An RT-LAMP-coupled CRISPR-Cas12 module for rapid, sensitive detection of SARS-CoV-2.
    Ali Z; Aman R; Mahas A; Rao GS; Tehseen M; Marsic T; Salunke R; Subudhi AK; Hala SM; Hamdan SM; Pain A; Alofi FS; Alsomali A; Hashem AM; Khogeer A; Almontashiri NAM; Abedalthagafi M; Hassan N; Mahfouz MM
    Virus Res; 2020 Oct; 288():198129. PubMed ID: 32822689
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Applications of the CRISPR-Cas system for infectious disease diagnostics.
    Li P; Wang L; Yang J; Di LJ; Li J
    Expert Rev Mol Diagn; 2021 Jul; 21(7):723-732. PubMed ID: 33899643
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CRISPR-Cas systems for diagnosing infectious diseases.
    Kostyusheva A; Brezgin S; Babin Y; Vasilyeva I; Glebe D; Kostyushev D; Chulanov V
    Methods; 2022 Jul; 203():431-446. PubMed ID: 33839288
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The era of Cas12 and Cas13 CRISPR-based disease diagnosis.
    Singh M; Bindal G; Misra CS; Rath D
    Crit Rev Microbiol; 2022 Nov; 48(6):714-729. PubMed ID: 35164636
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An ultrasensitive and specific point-of-care CRISPR/Cas12 based lateral flow biosensor for the rapid detection of nucleic acids.
    Mukama O; Wu J; Li Z; Liang Q; Yi Z; Lu X; Liu Y; Liu Y; Hussain M; Makafe GG; Liu J; Xu N; Zeng L
    Biosens Bioelectron; 2020 Jul; 159():112143. PubMed ID: 32364943
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CRISPR-cas systems based molecular diagnostic tool for infectious diseases and emerging 2019 novel coronavirus (COVID-19) pneumonia.
    Xiang X; Qian K; Zhang Z; Lin F; Xie Y; Liu Y; Yang Z
    J Drug Target; 2020; 28(7-8):727-731. PubMed ID: 32401064
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CRISPR-based point-of-care diagnostics incorporating Cas9, Cas12, and Cas13 enzymes advanced for SARS-CoV-2 detection.
    Verma MK; Roychowdhury S; Sahu BD; Mishra A; Sethi KK
    J Biochem Mol Toxicol; 2022 Aug; 36(8):e23113. PubMed ID: 35642647
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CRISPR-Cas12/Cas13: Bibliometric analysis and systematic review of its application in infectious disease detection.
    Leta S; Chibssa TR; Paeshuyse J
    J Infect Public Health; 2024 May; 17(5):741-747. PubMed ID: 38518680
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PrimedSherlock: a tool for rapid design of highly specific CRISPR-Cas12 crRNAs.
    Mann JG; Pitts RJ
    BMC Bioinformatics; 2022 Oct; 23(1):428. PubMed ID: 36241974
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Advances in the application of CRISPR-Cas technology in rapid detection of pathogen nucleic acid.
    Li X; Zhong J; Li H; Qiao Y; Mao X; Fan H; Zhong Y; Imani S; Zheng S; Li J
    Front Mol Biosci; 2023; 10():1260883. PubMed ID: 37808520
    [No Abstract]   [Full Text] [Related]  

  • 12. Development of CRISPR-Mediated Nucleic Acid Detection Technologies and Their Applications in the Livestock Industry.
    Zhang X
    Genes (Basel); 2022 Nov; 13(11):. PubMed ID: 36360244
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CRISPR/Cas Systems towards Next-Generation Biosensing.
    Li Y; Li S; Wang J; Liu G
    Trends Biotechnol; 2019 Jul; 37(7):730-743. PubMed ID: 30654914
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recent Improvements in CRISPR-Based Amplification-Free Pathogen Detection.
    Zhang J; Lv H; Li L; Chen M; Gu D; Wang J; Xu Y
    Front Microbiol; 2021; 12():751408. PubMed ID: 34659186
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CRISPR-based diagnostics for detection of pathogens.
    Bhattacharjee G; Gohil N; Lam NL; Singh V
    Prog Mol Biol Transl Sci; 2021; 181():45-57. PubMed ID: 34127201
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CRISPR technology incorporating amplification strategies: molecular assays for nucleic acids, proteins, and small molecules.
    Feng W; Newbigging AM; Tao J; Cao Y; Peng H; Le C; Wu J; Pang B; Li J; Tyrrell DL; Zhang H; Le XC
    Chem Sci; 2021 Mar; 12(13):4683-4698. PubMed ID: 34163728
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CRISPR-Cas12-Based Diagnostic Applications in Infectious and Zoonotic Diseases.
    Li L; Li S; Gu D; Xu Y; Wang J
    Methods Mol Biol; 2023; 2621():267-278. PubMed ID: 37041450
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CRISPR/Cas-based nucleic acid detection strategies: Trends and challenges.
    Zhou J; Li Z; Seun Olajide J; Wang G
    Heliyon; 2024 Feb; 10(4):e26179. PubMed ID: 38390187
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CREST, a Cas13-Based, Rugged, Equitable, Scalable Testing (CREST) for SARS-CoV-2 Detection in Patient Samples.
    Aralis Z; Rauch JN; Audouard M; Valois E; Lach RS; Solley S; Baxter NJ; Kosik KS; Wilson MZ; Acosta-Alvear D; Arias C
    Curr Protoc; 2022 Feb; 2(2):e385. PubMed ID: 35195954
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CRISPR-Cas-based techniques for pathogen detection: Retrospect, recent advances, and future perspectives.
    Huang T; Zhang R; Li J
    J Adv Res; 2023 Aug; 50():69-82. PubMed ID: 36367481
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.